Vascular endothelial growth factor receptor 2 (VEGFR2) is implicated in CSCs that can trigger blebbishield emergency program-mediated sphere formation in RT4 (transitional cell papilloma) bladder cancer cells [63]. Here, KDR is linked to urinary bladder cancer.